DCPH News and Press, Deciphera Pharmaceuticals Inc. From 08/18/22

Gainers: Microvast Holdings ( MVST ) +19% . Hydrofarm Holdings Group ( HYFM ) +7% . Mammoth Energy Services ( TUSK ) +5% . Twist Bioscience ( TWST ) +5% . Certara ( CERT ) +5% . Losers: Bed Bath & Beyond ( BBBY ) ...

– Efficacy Observed with QINLOCK® was Comparable to Sunitinib with a More Favorable Safety and Tolerability Profile in GIST Patients Previously Treated with Imatinib – Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focu...

Deciphera Pharmaceuticals, Inc. (DCPH) Q2 2022 Earnings Conference Call August 04, 2022, 8:00 AM ET Company Participants Jennifer Larson - Senior Vice President, Finance and Investor Relations Steven Hoerter - President and Chief Executive Officer Matthew Sherman...

Deciphera Pharmaceuticals press release ( NASDAQ: DCPH ): Q2 GAAP EPS of -$0.60 beats by $0.06 . Revenue of $32.5M (+37.9% Y/Y) beats by $2.39M . For further details see: Deciphera Pharmaceuticals GAAP EPS of -$0.60 beats by $0.06, revenue of $32.5M beats...

– Second Quarter 2022 Total Revenue of $32.5 Million; QINLOCK ® Net Product Revenue Increases 43% to $31.5 Million Compared to Second Quarter 2021 – – Phase 1 Single Agent Dose Escalation Data for DCC-3116 Selected for Oral Presentation as a P...

Deciphera Pharmaceuticals ( NASDAQ: DCPH ) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open. The consensus EPS Estimate is -$0.67 (vs. -$1.21 last year) and the consensus Revenue Estimate is $30.11M (+27.7% Y/Y). Over the last 3 ...

ABMD , ABUS , ACIW , ADAP , OTCQX:ADDYY , ADT , AG , AGIO , AHH , APD , APO , APTV , ARW , ATI , AUPH , AUTL , AZEK , BABA , BALL , BALY , OTCPK:BAYZF , BCE , BCRX , BDX , BKI , CBRE , ...

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it will report its second quarter 2022 financial results on Thursd...

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that in connection with the hiring of Kelley Dealhoy, Senior Vice Presi...

Gainers: Option Care Health ( OPCH ) +8% . Bed Bath & Beyond ( BBBY ) +6% . Deciphera Pharmaceuticals ( DCPH ) +5% . GoodRx Holdings ( GDRX ) +4% . Redfin Corporation ( RDFN ) +4% . Losers: MIND Technology ( MINDP ...